Hormone & Support
$75
10 vials · 5 mg. Price is for 10 vials.
Growth hormone–releasing factor analog approved to reduce excess abdominal fat in HIV-infected adults with lipodystrophy — not a general weight-loss medicine.
Strength
Quantity
Sold in packs of 10 vials. Tesamorelin 5 mg is priced per pack, not per milligram.
Need help? Contact on Telegram.
Research-use vials sold in packs of 10. Not a medicine and not for human or veterinary use. This catalog is not medical advice. Checkout is Telegram; see terms and privacy.
Intended use: research-use lyophilized peptide. This listing is not a medicine and not for human or veterinary use.
Form: powder in multi-dose vials. Pack of 10 vials at 5 mg.
Storage: keep lyophilized vials cool, dry, and away from sunlight. This page does not provide mixing steps or injection technique.
Tesamorelin is a synthetic analog of growth hormone-releasing factor (GHRH/GHRF). It is FDA-approved for a narrow indication: reduction of excess abdominal fat in HIV-infected adults with lipodystrophy. Labeling states it is not indicated for weight-loss management and that long-term cardiovascular safety has not been established.
Educational answers from the research profile. Not treatment advice.
A GHRH analog approved to reduce excess abdominal fat in HIV-infected adults with lipodystrophy.
Labeling says it is not indicated for weight-loss management. The approved use is specific.
It stimulates pituitary GH release via GHRH receptors, with downstream metabolic effects on visceral fat in the studied indication.
Malignancy-related warnings, glucose effects, injection-site reactions, and unknown long-term cardiovascular safety are among labeled issues.